Pfizer Could Apply for Emergency Use of COVID-19 Vaccine by Late November
Share
[aggregation-styles]
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
Local /
7 hours ago
Former Student Charged With Attempted Murder in Knife Attack at Porterville’s Monache High
Crime /
8 hours ago
Fresno Police Arrest Felon on Probation After Finding Concealed Gun
News /
8 hours ago
What Does It Mean for Biden’s Prostate Cancer to Be ‘Aggressive’? A Urologic Surgeon Explains
World /
8 hours ago
Netanyahu Says Israel Probably Killed Hamas Leader Mohammed Sinwar
Crime /
8 hours ago
California Cop Was Partying at Festival While Collecting $600,000 for Fake Injury
Politics /
9 hours ago
